RADHAKISHAN PHARMACEUTICALS
BORTECAD  BORTEZOMIB INJECTION

BORTECAD BORTEZOMIB INJECTION

MOQ : 1 Bottle

BORTECAD BORTEZOMIB INJECTION Specification

  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Origin of Medicine
  • Imported
  • Indication
  • Multiple Myeloma, Mantle Cell Lymphoma
  • Salt Composition
  • Bortezomib
  • Dosage Form
  • Injection
  • Drug Type
  • Allopathic
  • Ingredients
  • Bortezomib
  • Physical Form
  • Liquid
  • Function
  • Anti-Cancer
  • Recommended For
  • As directed by physician
  • Dosage
  • As prescribed by physician
  • Dosage Guidelines
  • Follow healthcare providers instructions
  • Suitable For
  • Adults
  • Quantity
  • 1 Vial
  • Storage Instructions
  • Store below 25C. Protect from light.
  • Pack Type
  • Vial
  • Shelf Life
  • 24 Months
  • Route of Administration
  • Intravenous or Subcutaneous
  • Brand Name
  • Bortecad
  • Marketed By
  • Cadila Healthcare Ltd.
  • Strength
  • 2 mg/vial
  • Use under medical supervision
  • Yes
  • Prescription/Non prescription
  • Prescription
 

BORTECAD BORTEZOMIB INJECTION Trade Information

  • Minimum Order Quantity
  • 1 Bottle
  • Packaging Details
  • PACK OF 1 VIAL
 

About BORTECAD BORTEZOMIB INJECTION

PRODUCT DETAILS

BRAND NAME: BORTECAD

CONTENT: BORTEZOMIB

STRENGTH: 2MG

PACKAGING: PACK OF 1 VIAL

MANUFACTURED BY: CADILA

Note:-Bortecad Is APrescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From AProblem That Is Not Effectively Treated By This Drug.............



Precisely Formulated Anti-Cancer Therapy

Bortecad is formulated with bortezomib, a potent anti-cancer agent. It is particularly effective in managing multiple myeloma and mantle cell lymphoma, offering targeted action against malignant cells. As an allopathic injection, it acts directly through the bloodstream, allowing for rapid therapeutic response.


Safe Administration and Usage Guidelines

This medication is available only under prescription and should be administered intravenously or subcutaneously by medical professionals. Dosage and treatment duration are tailored to each patient by the physician. Following healthcare provider instructions is critical to ensure optimal efficacy and minimize risks.


Storage and Handling Precautions

Bortecad requires careful storage below 25C, protected from direct light to preserve its stability and effectiveness. Always keep the packaging intact until use and handle with medical supervision. The recommended shelf life ensures potency for up to two years from manufacturing.

FAQs of BORTECAD BORTEZOMIB INJECTION:


Q: How is Bortecad (Bortezomib Injection) administered?

A: Bortecad is administered either intravenously or subcutaneously by a healthcare professional in a clinical setting. The exact route and dosage depend on the patients specific medical condition and physicians instructions.

Q: What conditions is Bortecad recommended for?

A: Bortecad is primarily indicated for the treatment of multiple myeloma and mantle cell lymphoma. Its anti-cancer properties make it suitable for targeting malignant cells in these conditions.

Q: When should Bortecad be used during treatment?

A: Bortecad should be used as part of a prescribed anti-cancer regimen and only under strict medical supervision. The timing and duration of treatment are determined by the physician based on individual patient needs.

Q: Where should Bortecad be stored before administration?

A: Bortecad must be stored below 25C in a cool, dark place, away from direct sunlight. Maintaining recommended conditions ensures the injections stability and potency until use.

Q: What is the process for using Bortecad safely?

A: This medication should always be prepared and administered by qualified healthcare providers. Patients must follow dosage and scheduling instructions precisely, as directed by their physician, to reduce risks and maximize therapeutic benefit.

Q: What are the benefits of Bortecad in cancer therapy?

A: Bortecad delivers targeted anti-cancer effects, helping manage and treat multiple myeloma and mantle cell lymphoma. It contributes to reducing cancer cell proliferation and may improve overall patient outcomes when used as part of a comprehensive treatment plan.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

RICOVIR EM EMTRICITABINE  TANOFOVIR TABLETS

RICOVIR EM EMTRICITABINE TANOFOVIR TABLETS

Minimum Order Quantity : 1 Bottle

Function : Other, Antiretroviral therapy (ART)

Drug Type : Other, Generic

Salt Composition : Emtricitabine 200mg & Tenofovir Disoproxil Fumarate 300mg

Dosage Form : Tablet

Indication : Preexposure prophylaxis (PrEP) and treatment of HIV1 infection

LEDIHEP SOFOSBUVIR  LEDIPASVIR TABLETS

LEDIHEP SOFOSBUVIR LEDIPASVIR TABLETS

Minimum Order Quantity : 1 Bottle

Function : Other, Antiviral medication; inhibits HCV replication

Drug Type : Other, Allopathic

Salt Composition : Sofosbuvir and Ledipasvir

Dosage Form : Oral tablets

Indication : Treatment of chronic hepatitis C (HCV genotype 1, 4, 5, and 6)

ZOLETRUST ZOLEDRONIC ACID INJECTION

ZOLETRUST ZOLEDRONIC ACID INJECTION

Function : Other, Prevention and treatment of osteoporosis and related bone conditions

Drug Type : Injection

Salt Composition : Zoledronic Acid

Dosage Form : Injection

Indication : Osteoporosis in postmenopausal women and men, Pagets disease of bone, Hypercalcemia of malignancy

LEDIKAST LEDIPASVIR TABLETS

LEDIKAST LEDIPASVIR TABLETS

Function : Other, Antiviral medication for hepatitis C

Drug Type : Other, Prescription medicine

Salt Composition : Ledipasvir 90mg

Dosage Form : Oral tablet

Indication : Treatment of Hepatitis C Genotype 1 infection



Back to top